InflaRx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
IFRX Key Statistics
Stock Snapshot
With a market cap of 67.13M, InflaRx(IFRX) trades at $1.00. The stock has a price-to-earnings ratio of -0.95.
During the trading session on 2026-01-14, InflaRx(IFRX) shares reached a daily high of $1.04 and a low of $1.00. At a current price of $1.00, the stock is 0.0% higher than the low and still -3.8% under the high.
Trading volume for InflaRx(IFRX) stock has reached 94.66K, versus its average volume of 691.52K.
Over the past 52 weeks, InflaRx(IFRX) stock has traded between a high of $2.77 and a low of $0.71.
Over the past 52 weeks, InflaRx(IFRX) stock has traded between a high of $2.77 and a low of $0.71.
IFRX News
Claim 70% Off TipRanks Premium InflaRx ( (IFRX) ) has shared an update. On January 8, 2026, InflaRx announced a strategic realignment that sharply prioritizes...
InflaRx (IFRX) is undertaking measures to reduce spending, extend the Company’s cash runway, and align resources to enable further development of izicopan in HS...